155 related articles for article (PubMed ID: 31732192)
1. Structural bases that underline Trypanosoma cruzi calreticulin proinfective, antiangiogenic and antitumor properties.
Peña Álvarez J; Teneb J; Maldonado I; Weinberger K; Rosas C; Lemus D; Valck C; Olivera-Nappa Á; Asenjo JA; Ferreira A
Immunobiology; 2020 Jan; 225(1):151863. PubMed ID: 31732192
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis.
Ramírez-Toloza G; Sosoniuk-Roche E; Valck C; Aguilar-Guzmán L; Ferreira VP; Ferreira A
Trends Parasitol; 2020 Apr; 36(4):368-381. PubMed ID: 32191851
[TBL] [Abstract][Full Text] [Related]
3. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.
Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A
PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
[TBL] [Abstract][Full Text] [Related]
5. Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression.
González A; Härtel S; Mansilla J; Sánchez-Valdéz F; Ferreira A
Immunobiology; 2018 Dec; 223(12):802-806. PubMed ID: 30131175
[TBL] [Abstract][Full Text] [Related]
6. The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence.
Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Ferreira VP; Ferreira A
Front Immunol; 2020; 11():1561. PubMed ID: 32793217
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin.
Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A
Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.
López NC; Valck C; Ramírez G; Rodríguez M; Ribeiro C; Orellana J; Maldonado I; Albini A; Anacona D; Lemus D; Aguilar L; Schwaeble W; Ferreira A
PLoS Negl Trop Dis; 2010 Jul; 4(7):e730. PubMed ID: 20625551
[TBL] [Abstract][Full Text] [Related]
9. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth.
Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A
Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211
[TBL] [Abstract][Full Text] [Related]
10. Is It Possible to Intervene in the Capacity of
Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
Front Immunol; 2021; 12():789145. PubMed ID: 34975884
[TBL] [Abstract][Full Text] [Related]
11. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
[TBL] [Abstract][Full Text] [Related]
12. Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?
Ramírez-Toloza G; Abello P; Ferreira A
Front Immunol; 2016; 7():268. PubMed ID: 27462315
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
14. Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis?
Ferreira V; Molina MC; Schwaeble W; Lemus D; Ferreira A
Trends Parasitol; 2005 Apr; 21(4):169-74. PubMed ID: 15780838
[TBL] [Abstract][Full Text] [Related]
15. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi.
Ferreira V; Valck C; Sánchez G; Gingras A; Tzima S; Molina MC; Sim R; Schwaeble W; Ferreira A
J Immunol; 2004 Mar; 172(5):3042-50. PubMed ID: 14978109
[TBL] [Abstract][Full Text] [Related]
16. An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis.
Molina MC; Ferreira V; Valck C; Aguilar L; Orellana J; Rojas A; Ramirez G; Billetta R; Schwaeble W; Lemus D; Ferreira A
Mol Biochem Parasitol; 2005 Apr; 140(2):133-40. PubMed ID: 15760653
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.
Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A
Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323
[TBL] [Abstract][Full Text] [Related]
18. In vitro Treatment of a Murine Mammary Adenocarcinoma Cell Line with Recombinant Trypanosoma cruzi Calreticulin Promotes Immunogenicity and Phagocytosis.
Sosoniuk-Roche E; Cruz P; Maldonado I; Duaso L; Pesce B; Michalak M; Valck C; Ferreira A
Mol Immunol; 2020 Aug; 124():51-60. PubMed ID: 32526557
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.
González A; Valck C; Sánchez G; Härtel S; Mansilla J; Ramírez G; Fernández MS; Arias JL; Galanti N; Ferreira A
Am J Trop Med Hyg; 2015 May; 92(5):887-97. PubMed ID: 25758653
[TBL] [Abstract][Full Text] [Related]
20. Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection?
Abello-Cáceres P; Pizarro-Bauerle J; Rosas C; Maldonado I; Aguilar-Guzmán L; González C; Ramírez G; Ferreira J; Ferreira A
BMC Cancer; 2016 Sep; 16(1):731. PubMed ID: 27619675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
